Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas – PRODIGE 19 – FFCD1103

Publication | Open Access

Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas – PRODIGE 19 – FFCD1103 – ADCI002

DOI Full Paper Access

Citations

References

2013

Year

Guillaume Piessen, Mathieu Messager, Karine Le Malicot, William B. Robb, Frédéric Di Fiore, Marie Guilbert, Marie Moreau, Véronique Christophe, Antoine Adenis, C. Mariette

BMC Cancer